These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35908243)

  • 21. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
    Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
    Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.
    McClements ME; Staurenghi F; MacLaren RE; Cehajic-Kapetanovic J
    Front Neurosci; 2020; 14():570909. PubMed ID: 33262683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optogenetic restoration of high sensitivity vision with bReaChES, a red-shifted channelrhodopsin.
    Too LK; Shen W; Protti DA; Sawatari A; A Black D; Leamey CA; Y Huang J; Lee SR; E Mathai A; Lisowski L; Y Lin J; C Gillies M; Simunovic MP
    Sci Rep; 2022 Nov; 12(1):19312. PubMed ID: 36369267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases.
    Yan B; Nirenberg S
    IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optogenetic approaches to vision restoration.
    Simunovic MP; Shen W; Lin JY; Protti DA; Lisowski L; Gillies MC
    Exp Eye Res; 2019 Jan; 178():15-26. PubMed ID: 30218651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optopharmacological tools for restoring visual function in degenerative retinal diseases.
    Tochitsky I; Kramer RH
    Curr Opin Neurobiol; 2015 Oct; 34():74-8. PubMed ID: 25706312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging therapies for inherited retinal degeneration.
    Scholl HP; Strauss RW; Singh MS; Dalkara D; Roska B; Picaud S; Sahel JA
    Sci Transl Med; 2016 Dec; 8(368):368rv6. PubMed ID: 27928030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial recovery of visual function in a blind patient after optogenetic therapy.
    Sahel JA; Boulanger-Scemama E; Pagot C; Arleo A; Galluppi F; Martel JN; Esposti SD; Delaux A; de Saint Aubert JB; de Montleau C; Gutman E; Audo I; Duebel J; Picaud S; Dalkara D; Blouin L; Taiel M; Roska B
    Nat Med; 2021 Jul; 27(7):1223-1229. PubMed ID: 34031601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease.
    Beltran WA; Cideciyan AV; Iwabe S; Swider M; Kosyk MS; McDaid K; Martynyuk I; Ying GS; Shaffer J; Deng WT; Boye SL; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):E5844-53. PubMed ID: 26460017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optogenetic restoration of retinal ganglion cell activity in the living primate.
    McGregor JE; Godat T; Dhakal KR; Parkins K; Strazzeri JM; Bateman BA; Fischer WS; Williams DR; Merigan WH
    Nat Commun; 2020 Apr; 11(1):1703. PubMed ID: 32245977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Optogenetics and prosthetic treatment of retinal degeneration].
    Kirpichnikov MP; Ostrovskiy MA
    Vestn Oftalmol; 2015; 131(3):99-111. PubMed ID: 26310015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation-Independent Gene Therapies for Rod-Cone Dystrophies.
    Fortuny C; Flannery JG
    Adv Exp Med Biol; 2018; 1074():75-81. PubMed ID: 29721930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic comparison of optogenetic approaches to visual restoration.
    Gilhooley MJ; Lindner M; Palumaa T; Hughes S; Peirson SN; Hankins MW
    Mol Ther Methods Clin Dev; 2022 Jun; 25():111-123. PubMed ID: 35402632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards optogenetic vision restoration with high resolution.
    Ferrari U; Deny S; Sengupta A; Caplette R; Trapani F; Sahel JA; Dalkara D; Picaud S; Duebel J; Marre O
    PLoS Comput Biol; 2020 Jul; 16(7):e1007857. PubMed ID: 32667921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for expanding the operational range of channelrhodopsin in optogenetic vision.
    Mutter M; Münch TA
    PLoS One; 2013; 8(11):e81278. PubMed ID: 24312285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations.
    Léveillard T; Klipfel L
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for inherited retinal degenerations: initial successes and future challenges.
    Gupta PR; Huckfeldt RM
    J Neural Eng; 2017 Oct; 14(5):051002. PubMed ID: 28829759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions.
    Montazeri L; El Zarif N; Trenholm S; Sawan M
    IEEE Trans Biomed Circuits Syst; 2019 Dec; 13(6):1792-1807. PubMed ID: 31689206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.